Lotus Pharmaceutical Co., Ltd

Lotus Pharmaceutical Co., Ltd company information, Employees & Contact Information

美時化學製藥股份有限公司(股票代碼:1795)成立於 1966 年,是一家全球性的製藥公司。美時專注於新藥和學名藥的商業化,致力爲患者提供更好、更安全、更易取得的藥品。公司擁有亞洲公認的一流研發和製造平台,並在包括美國、歐洲、日本、中國和巴西在內的幾乎所有全球市場建立了合作夥伴關係。美時在亞洲和美國進行超過 100 多個戰略選擇的製藥項目,其中包括 250 多種商業化產品。公司通過內部研發投資和合作授權,投資高門檻的腫瘤用藥、複雜學名藥以及 505(b)2 和 NCE 組成的多元化最佳產品組合,並透過戰略合作夥伴的支持下加強生物相似藥產品,以加强其產品組合競爭力。美時有亞洲地區最頂尖的研發中心與生產設備,也是台灣唯一同時獲得美國 FDA、歐盟 EMA、日本 PDMA、中國 FDA、及巴西 ANVISA 認證的藥廠。 Founded in 1966, Lotus (1795: TT) is an international pharmaceutical company with global presence, focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. The Company has a recognized best-in-class R&D and manufacturing platform in Asia and has established partnerships in nearly every global market including the U.S., Europe, Japan, China, and Brazil. Lotus runs over 100 strategically selected pharmaceutical projects in development and registrations across Asia and the US, with over 250 commercial products. The Company invests in diversified best portfolio consisting of high-barrier oncology, complex generics as well as 505(b)2 and NCE via internal R&D investment and licensing-in partnership, and also strengthens its portfolio competitiveness by adding biosimilar products with support from strategic partners. Its industry-leading infrastructure certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA.

Company Details

Employees
371
Founded
-
Address
Songren Road, 17f,no. 277,taiwan, Province Of China
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
信義區, 台北市
Looking for a particular Lotus Pharmaceutical Co., Ltd employee's phone or email?

Lotus Pharmaceutical Co., Ltd Questions

News

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia - LENZ Therapeutics

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia LENZ Therapeutics

LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY - PR Newswire

LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY PR Newswire

LENZ Therapeutics and Lotus Pharmaceutical Enter Exclusive Agreement for LNZ100 in Southeast Asia to Target Presbyopia Treatment - Nasdaq

LENZ Therapeutics and Lotus Pharmaceutical Enter Exclusive Agreement for LNZ100 in Southeast Asia to Target Presbyopia Treatment Nasdaq

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. - GlobeNewswire

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. GlobeNewswire

Lotus sets sights on building powerful regional health care platform - South China Morning Post

Lotus sets sights on building powerful regional health care platform South China Morning Post

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - PR Newswire APAC - 美通社

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - PR Newswire APAC 美通社

Top Lotus Pharmaceutical Co., Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant